Compounds useful for making hcv protease inhibitors

Christel Florentina E. Van Den Eynde, Herman Augustinus De Kock, Pierre Jean-Marie Bernard Raboisson, Gerben Albert Eleutherius Van't Klooster, Bioavailable combinations for hcv treatment ,(2007)

Nathan Yee, Fabrice Gallou, Ring-closing metathesis process in supercritical fluid ,(2005)

Chutian Shu, Ring-closing metathesis process for the preparation of macrocyclic peptides ,(2006)

Chu-Chung Lin, Pei-Chin Cheng, Yo-chin Liu, Chen-fu Liu, Chi-Hsin Richard King, None, Hcv protease inhibitors ,(2008)

Wendelin Samstag, Wolfgang Dersch, Process for the preparation of macrocyclic compounds ,(2004)

Joel D. Moore, Zhe Wang, Dong Liu, Deqiang Niu, Guoyou Xu, Yat Sun Or, Yonghua Gai, Ying Sun, Datong Tang, Macrocyclic hepatitis c virus serine protease inhibitors ,(2007)

Datong Tang, Joel D. Moore, Zhe Wang, Yat Sun Or, Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors ,(2007)

Viyyoor M. Girijavallabhan, Srikanth Venkatraman, F. George Njoroge, Depeptidized inhibitors of hepatitis c virus ns3 protease ,(2004)

David Monteith, Zhihui Qiu, Bruce Malcolm, Wing-Kee Cho, Jiansheng Wan, Kevin Alton, Controlled-release formulation of HCV protease inhibitor and methods using the same ,(2006)

Eric L. Elliott, Joel D. Moore, Zhe Wang, Yat Sun Or, Hydrazide-containing hepatitis c serine protease inhibitors ,(2007)